Related Experiment Videos
Classification of antiarrhythmic drugs
H Frumin1, N Z Kerin, M Rubenfire
1Department of Medicine, Sinai Hospital of Detroit, Michigan 48235-2099.
Journal of Clinical Pharmacology
|May 1, 1989
Summary
The Vaughan Williams classification system, categorizing antiarrhythmic drugs by their mechanism, remains a useful tool for understanding cardiac electrophysiology and treatment strategies. It groups drugs by their effects on sodium channels, beta-adrenergic receptors, action potential duration, and calcium channels.
Area of Science:
- Pharmacology
- Cardiology
- Electrophysiology
Background:
- Multiple classification schemes for antiarrhythmic drugs exist.
- The Vaughan Williams system, modified by Harrison, is widely accepted.
- This system categorizes drugs based on their electrophysiologic effects.
Purpose of the Study:
- To review the widely accepted Vaughan Williams classification of antiarrhythmic drugs.
- To discuss the electrophysiologic basis of this classification.
- To evaluate the strengths and weaknesses of the system.
Main Methods:
- Review of existing literature on antiarrhythmic drug classification.
- Analysis of the Vaughan Williams classification system.
- Discussion of electrophysiologic mechanisms and clinical observations.
Main Results:
- The Vaughan Williams system classifies drugs into four main categories: Class I (sodium channel blockers), Class II (beta-blockers), Class III (action potential prolongers), and Class IV (calcium channel blockers).
- The classification is largely based on clinical observation.
- The system has remained useful for nearly two decades.
Conclusions:
- The Vaughan Williams classification provides a valuable framework for understanding antiarrhythmic drugs.
- Despite its age, the system's basis in clinical observation ensures its continued relevance.
- Further discussion on its electrophysiologic underpinnings, strengths, and limitations is warranted.